Studies prove that mammography saves lives. The screening tool can detect breast cancer early when it’s still curable. But for the thousands of women with dense breast tissue, mammography is not enough. These women may need additional screening tests such as MRI‘s. Now, researchers at Mayo Clinic have developed new technology that can spot breast tumors in dense tissue at a fraction of the cost of MRI’s.
Research proves that screening for breast cancer with mammograms saves lives. But mammograms are not perfect. They can miss tumors, especially in women with dense breast tissue. That’s why Doctors at Mayo Clinic also use MRI’s to screen for breast cancer in high risk women. The technology can detect some tumors that mammograms cannot.
Healthy choices and active screening for breast cancer are your best defenses in beating the disease. Also learn about today’s breast cancer treatments so you can discuss them with your doctor.
Jacqueline’s brothers call her “The Baby,” but she didn’t back down from her fight with breast cancer. Learn about her treatment plan and hear her advice for those battling cancer.
See how cancer forms inside the breast, and learn the possible signs and symptoms of breast cancer.
The lesson learned in eradicating dandelions from your yard could apply in treating breast cancer as well, said researchers from Baylor College of Medicine in Houston in a report that appears online in the Journal of the National Cancer Institute.
“It’s not enough to kill the dandelion blossom and stalk that appear above ground,” said Dr. Michael Lewis, assistant professor of molecular and cellular biology and a faculty member in the Lester and Sue Smith Breast Cancer Center at BCM. “You have to kill the root beneath the soil as well.”
(more…)
A high consumption of lignans is associated with better survival in postmenopausal women with breast cancer. Although the dietary intake of lignans did not have any effect on breast cancer survival in premenopausal women, postmenopausal women with a high intake of plant lignans were approximately 70% less likely to die from their breast cancer, according to study data presented here at the American Association for Cancer Research 2008 Annual Meeting.
(more…)
A novel peptide vaccine was able to reduce the mortality rate in women with HER2/neu overexpressing breast cancer by about half, researchers report here at the American Association for Cancer Research (AACR) 2008 Annual Meeting.
“The numbers in this study are small but the concept is good,” commented William N. Hait, MD, PhD, president of the AACR and senior vice president of Worldwide Hematology and Oncology Research and Development at Johnson & Johnson. “It’s a good first step and we are cautiously optimistic.”
(more…)
A breast cancer patient’s age alone should not determine whether or not she receives standard breast-conservation treatments, including a lumpectomy and radiation therapy; however, if additional health problems (comorbidities) are present, treatments should be individualized based on age and the type of comorbidities, according to a study in the April 1 edition of the International Journal for Radiation Oncology Biology Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
(more…)
